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ABSTRACT 
The management of post operative patients is a multi dimensional approach of treatment. 
Many common problems are developed during post operative period. Pain is one of the 
biggest problems amongst them. Therefore, an effective pain control is very essential to 
manage pain for post operative patients. There are lots of analgesics available in modern 
medical science. But they are causing side effects to the patients. Considering above problems 
faced by patients, a potent, safe and effective analgesic and well known Vedanahara and 
Shoola prasamana drug Vrihat Panchamoola was selected for this study. In this study 50 lower 
segment caesarean section patients (L.S.C.S) registered from labour room of Prasutitantra 
Department, S.S. Hospital, I.M.S, B.H.U, Varanasi (U.P) were selected randomly and divided in 
two equal groups. Group-I as trial and Group-II as control group. The trial patients are given 
1000mg (two capsules of 500mg each) Ghanasatwa of Vrihat Panchamoola twice daily and the 
control group patients have given 50 mg Diclofenac Sodium twice daily after operation when 
bowel sound onset. After comparative study it has been found that, the trial drug Vrihat 
Panchmoola Ghanasatwa has produced good analgesic response during post operative pain 
management of L.S.C.S, patients.  
KEYWORDS: Post Operative, Pain, Lower Segment Caesarean Section (L.S.C.S), Vrihat 
Panchamoola, Ghanasatwa, Analgesic. 
INTRODUCTION 
Ayurveda is the most ancient medical 
science, which gives preventive as well as curative 
measures with least adverse effects. Now-a-days 
surgical procedures have done profusely for 
several diseases. But, there are so many common 
problems developed during post operative period 
due to psychophysical and neurohumoral 
alterations caused by anesthesia and surgical 
trauma. Pain is the biggest problem of the patients 
during immediate post operative period. The 
acute pain is produced due to tissue trauma, 
inflammation and tissue hypoxia[1]. So 
management of pain is a matter of great concern 
for physicians as well as surgeons for operative 
patients. Post operative pain not only produces 
discomfort to the patients, but at the same times it 
also interprets many systemic functions of the 
body. 
Though, many synthetic and semi-
synthetic analgesics are being used frequently for 
post operative pain relief, but none of them are 
devoid of their well known untoward effects. 
Therefore a potent, safe and effective analgesic 
having least side effects, the well known 
Vedanahara and Shoola prasamana drug Vrihat 
Panchamoola (Bilwa, Gambhari, Shyonaka, Patala 
and Agnimantha)[2] was selected for this study in 
Ghanasatwa form. 
In this study, 50 patients with narrow age, 
weight and height recommended for L.S.C.S 
operation were selected and randomly divided 
into two equal groups. Group-I was trial group 
and Group-II was control group. The patients of 
trial group has given 1000mg (two capsules of 
500mg each) Ghanasatwa of Vrihat Panchmoola 
twice daily and the patients of control group has 
given Diclofenc sodium 50mg twice daily orally 
with an ounce of plain water. It was observed that, 
the trial drug Vrihat Panchamoola Ghanasatwa 
given orally has produced good analgesic 
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response during post operative period after onset 
of bowel sound in L.S.C.S. patients. 
AIM AND OBJECTIVES  
I. To find out a potent, safe, effective and 
economic analgesic herbal drug having least 
adverse effects. 
II. To evaluate the analgesic effects of Vrihat 
Panchamoola Ghanasatwa in post operative 
L.S.C.S. patients. 
III. To find out the adverse effects if any of the 
trial drug. 
IV. Overall well being of the patients.  
MATERIALS AND METHODS 
For this study total 50 patients were 
registered from the labour room of Prasutitantra 
Department, S.S. Hospital, I.M.S, Banaras Hindu 
University, Varanasi during the year 2002-03. All 
patients were divided randomly into two equal 
and identical groups consisting of 25 each. 
Patients of Group-I were considered as trial group 
and advised to take Vrihat Panchamoola 
Ghanasatwa 1000mg twice daily with an ounce of 
plane water during post operative period after 
onset of bowel sound. Patients of Group-II were 
considered as control group and given tablet of 
Diclofenac sodium 50 mg orally in post operative 
period after onset of bowel sound. 
After the medication the response was 
noted for local tissue inflammation, condition of 
wound, onset of bowel sound, intensity of pain etc. 
The numbers were assigned (0-4) to measure the 
intensity of pain. Zero denotes no discomfort and 
four denotes unbearable pain as shown under[3]; 
0 - No discomfort, complete at ease.  
1 - Patient feeling a little discomfort. 
2 - Patient staying still, eyes closed and avoiding   
       movements. 
3 - Patient’s facial expressions strained.  
4 - Patient writing sweating and distressed. 
After completion of the study, the 
incidence of desirable and undesirable effects and 
incidences of adverse effects and nature of 
recovery were compared in both groups by Chi 
Square (x2) and Fisher exact probability tests[4] 
whenever needed. 
STUDY DESIGN 
The patients registered from the labour 
room of Prasuti and Streerog department, S.S. 
Hospital, Institute of Medical Sciences, B.H.U, 
Varanasi during the year 2003 have selected 
irrespective of their Age, Weight, Height. Religion 
etc. All the selected patients were given their 
consent for this study. 
OBSERVATION AND RESULTS 
In this study 50 selected trial patients 
were divided in two groups i.e. Group-I (Trial 
group) and Group-II (Control group). 
Table 1: Showing the number of patients in both 
groups and their drug regimen 
Group No. of 
Patients 
Drug Regimen 
I (Trial) 25 Two capsules (500mg 
each) twice daily of trial 
drug compound with an 
ounce of plain water 
given after L.S.C.S (after 
onset of bowel sound)  
II 
(Control) 
25 One tablet of Diclofenac 
Sodium 50mg given with 
ounce of water after 
L.S.C.S (after onset of 
bowel sound). 
Table 2: Showing the mean post operative pain 
score (V.A.S) of both groups 
Group Before 
Treatment 
After Treatment 
I 5.72 ±1.38 2.53 ± 1.23 
II 5.4± 0.76 2.49± 1.24 
Table3: Statistical comparison of post operative 
pain score (V.A.S) within the groups 
Group Before Treatment Vs After Treatment 
I t= 7.41 
p<0.001 (Highly Significant) 
II t=9.7 
p<0.001 (Highly Significant) 
Table 4: Statistical comparison of post operative 
pain score (V.A.S) between the groups 
Group Before Treatment After 
Treatment 
I Vs II 
 
t=0.8 
p< 1 (Not Significant) 
t=0.12 
P < 1 (Not 
Significant) 
Comments: The mean post operative pain score 
(V.A.S) before treatment and after treatment in 
patients of Group-I is 5.72 ± 1.38, 2.53± 1.23 and 
in Group-II is 5.4 ± 0.76, 2.49± 1.24 respectively. 
The statistical difference before treatment and 
after treatment within the groups is highly 
significant. However, the differences of pain score 
are statistically insignificant between the group 
comparisons. 
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Table 5: Showing the mean postoperative pain score 
(O.A.D) in patients of the groups 
Group Before Treatment After 
Treatment 
I 2.96 ± 0.45 1.39 ± 0.18 
II 2.84 ± 0.37 1.30 ± 0.21 
Table 6: Statistical comparison of post operative pain 
score (O.A.D) within the groups 
Group Before Treatment Vs After Treatment 
I t = 9.61 
p < 0.001(Highly Significant) 
II t = 3.34 
p < 0.01 (Highly Significant) 
Table 7: Statistical comparison of post operative pain 
score (O.A.D) between the groups 
Group Before Treatment After 
Treatment 
I Vs II t = 1.02 
p < 0.05 (Not 
Significant) 
t= 1.55 
p < 0.05 (Not 
Significant) 
 Comments: The mean post operative pain score 
(O.A.D), before treatment and after treatment in 
patients of Group-I is 2.96 ± 0.45, 1.39 ± 0.18 and 
in Group II is 2.84 ± 0.37, 1.30 ± 0, 21 respectively. 
The statistical difference before treatment and 
after treatment within the group is highly 
significant. However between the groups it is 
insignificant.  
Table 8: Showing the mean time required (Hrs) for 1st 
and 2nd dose analgesic 
Group 1st dose required 
time (Hrs) 
2nd dose required 
time(Hrs) 
I 23.5 ± 6.13  32.24 ± 5.95 
II 23.36 ± 5.66 33.32 ± 6.33 
Table 9: Statistical comparison of time required for 
1st and 2nd dose analgesic between the groups 
Group 1st  dose required 
time (Hrs) 
2nd dose required 
time (Hrs)  
I Vs II t = 0.11 
p < 1 (Not 
Significant) 
t= 0.63 
p < 1 (Not 
Significant) 
Comments: The mean 1st and 2nd dose analgesic 
requirement time in patients of group I is 23.5 ± 
6.13, 32.24 ± 5.95 and in group-II is 23.36 ± 5.66, 
33.32 ± 6.33 respectively. The statistical 
difference between the groups is insignificant. 
Table 10: Showing the adverse effects of the trial 
drug compound and control drug in patients of 
both groups 
Group Nausea Vomiting Diarrhea Gastric 
irritation 
I Nil Nil Nil Nil 
II 4 
(16%) 
2 
(8%) 
1 
(4%) 
2 
(8%) 
 Comments: The above table shows that the trial 
drug compound has almost no adverse effects, 
whereas some patients under control drug 
complained nausea, vomiting, diarrhea and gastric 
irritation; which is well known and no significant 
relevance. 
Table 11: Showing the condition of wound in 
patients of both groups 
Group Inflammation Color Discharge 
Present 
  Normal 
Reddish 
Present 
I 1(4%) 24 (96%) 
1(4%)  
- 
II 2 (8%)  23(92%) 
2(8%) 
- 
 From the above table it is observed that none of 
the patients have shown any wound complication. 
However the inflammation and reddish color of 
wound was observed in 4 to 8% patients of both 
groups, which is almost identical and not clinically 
serious. 
Table 12: Showing the mean of total hospital stay 
(in days) in both groups 
Group Mean number of days ± S.D. 
I 8.8 ± 0.5 
II 8.84 ± 0.7 
 Table 13: Statistical comparison between both 
groups 
Group No. of days 
I Vs II t = 0.25 
p < 1 (Not significant) 
Comments: The mean of total hospital stay of 
both groups are 8.8 ± 0.5 and 8.84 ± 0.7. The 
difference of total hospital stay between the 
groups is not statistically significant. 
DISCUSSION 
The post operative pain is the 
extraordinary complex sensation of afferent 
nociceptive stimulation and stimulation of higher 
centers. In post operative period degree of 
discomfort due to pain varies with patient to 
patient. The site of operation is also important 
factor to determine the severity of post operative 
pain. It has been also assumed that age, gender 
and body weight are important factors in pain 
perception and responds to analgesic drugs. 
Despite of many advances in the field of 
pharmacology, pain during post operative period 
has always been a global problem in the field of 
surgery. Pain itself not only produces distress to 
the patient during post operative periods affecting 
the physical and psychological harmony but also 
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influences psychological and neurohumoral 
variations. Morphine and its derivatives have been 
used in regular practice to pacify the pain of 
different origin. The use of synthetic and semi-
synthetic preparations no doubt significantly 
reduces the pain, but no one can deny to 
experience their well known on towards effects 
i.e. Respiratory depression, emesis, constipation, 
loss of appetite and addiction etc. Therefore, post 
operative pain relief remains as a great concern 
till date. 
A thorough research has been made in the 
texts of Ayurveda to evaluate some effective, 
potent and safe analgesic drugs for the post 
operative pain relief. The pioneers of Ayurveda 
have advocated many analgesic drugs under 
Vedana shamaka and Vatahara groups. For this 
clinical trial, drugs of Vrihat Panchamoola (Bilva, 
Gambhari, Shyonaka, Patala & Agnimantha) were 
selected and used in form of Ghanasatwa. The 
compound mixture of these five drugs was filled in 
capsule, containing 500mg in each capsule and 
given two capsules twice a day and found 
satisfactory, safe and good analgesic effect on post 
operative management in patients of lower 
segment caesarean section. The trial drug 
compound has almost identical analgesic 
properties with tablet Diclofenac Sodium used for 
post operative pain management. 
CONCLUSION 
On the basis of above observations and 
discussions it can be concluded the whole clinical 
trial as follows: 
i) The trial drug compound Vrihat Panchamoola 
(Bilwa, Gambhari, Shyonaka, Patala and 
Agnimantha) in the form of Ghanasatwa given 
orally, produces good analgesic response during 
post operative period in L.S.C.S. patients. 
ii) The trial drug compound is capable to minimize 
the post operative pain and found almost identical 
as compared to Diclofenac Sodium in terms of 
pain relief and duration of action. 
iii) The trial drug compound did not show any 
cardio-vascular and respiratory depression at any 
stage of whole observation. 
iv) The trial drug compound Vrihat Panchamoola 
did not show any significant untoward effect 
during post operative period. 
v) Vatashamaka, Vedanahara and Shoola 
prasamana properties of the trial drug compound 
have kept the better wound condition and good 
analgesic action post operatively. 
Thus in nut shell, this can be concluded 
that the trial drug compound can be used for the 
better post operative management as a potent 
analgesic,  anti inflammatory and anti phlogogenic 
agent in patients where oral medication is allowed 
post operatively. An indigenous analgesic drug is 
the need of the millennium. Hence, it is required 
to explore more comprehensive observation and 
investigations to reach the final conclusion.  
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